These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2534723)

  • 1. Clinical and pathophysiological aspects of fatty liver of unknown etiology in modern Japan.
    Iwamura K
    Tokai J Exp Clin Med; 1989 Apr; 14(2):61-85. PubMed ID: 2534723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical aspects and morphology of fatty dystrophy of the liver].
    Bondar' ZA; Podymova SD; Burchakova GI
    Klin Med (Mosk); 1970 Aug; 48(8):104-12. PubMed ID: 5476031
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis, clinical aspects and biochemistry of fatty liver].
    Müting D; Fischer R; Korn U; Reikowski J
    Dtsch Med Wochenschr; 1973 Apr; 98(14):733-7. PubMed ID: 4266619
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
    Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease and diabetes mellitus.
    Adams LA
    Endocr Res; 2007; 32(3):59-69. PubMed ID: 18092195
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis, clinical aspects and development of fatty liver].
    Eitel B; Kleine FD; Kleine S
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(3):111-6. PubMed ID: 4042954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty metamorphosis of the liver in morbid obesity.
    Kern WH; Heger AH; Payne JH; DeWind LT
    Arch Pathol; 1973 Nov; 96(5):342-6. PubMed ID: 4741905
    [No Abstract]   [Full Text] [Related]  

  • 9. New insights in the pathogenesis of non-alcoholic fatty liver disease.
    Gaemers IC; Groen AK
    Curr Opin Lipidol; 2006 Jun; 17(3):268-73. PubMed ID: 16680031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of laparoscopy in the diagnosis of hepatic steatosis].
    De la Revilla L; Martiń-Vivaldi R; Cano Bueso F
    Rev Esp Enferm Apar Dig; 1982 Mar; 61(3):218-24. PubMed ID: 6213001
    [No Abstract]   [Full Text] [Related]  

  • 11. Light microscopic and electron microscopic study on morphologic features resulting in the delay of ICG elimination in diabetic and non-diabetic fatty liver.
    Inaba R; Inaba M; Iwamura K
    Tokai J Exp Clin Med; 1984 Aug; 9(3):207-16. PubMed ID: 6537668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients.
    Jin HB; Gu ZY; Yu CH; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):389-92. PubMed ID: 16109522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver in diabetes mellitus.
    J Tenn Med Assoc; 1981 Jul; 74(7):514-5. PubMed ID: 7278248
    [No Abstract]   [Full Text] [Related]  

  • 14. Etiology and management of acute fatty liver of pregnancy.
    Snyder RR; Hankins GD
    Clin Perinatol; 1986 Dec; 13(4):813-25. PubMed ID: 3539453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steatosis and cirrhosis secondary to insulin resistance in children. Possible physiopathological mechanisms].
    Bonet Serra B; Barrio Merino A; Quintanar Rioja A; Alavés Buforn M; Nevado Santos M
    An Esp Pediatr; 2002 Apr; 56(4):353-6. PubMed ID: 11927081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morhpological and clinical findings in the liver in diabetes mellitus].
    Takác A; Langsch HG; Cossel L
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):188-97. PubMed ID: 5595286
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatty changes in the liver: the relation to age, overweight and diabetes mellitus.
    Hornbøll P; Olsen TS
    Acta Pathol Microbiol Immunol Scand A; 1982 May; 90(3):199-205. PubMed ID: 7102315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis: what we know in the new millennium.
    Harrison SA; Kadakia S; Lang KA; Schenker S
    Am J Gastroenterol; 2002 Nov; 97(11):2714-24. PubMed ID: 12425538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the clinical picture of fatty degeneration of the liver and fatty liver].
    Teichmann W; Lindemann A
    Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.